Next‑generation ECG interpretation
Our proprietary deep learning models detect over 95 distinct electrophysiological patterns covering 92% of common and rare arrhythmias, enabling early intervention and precision monitoring.
Explore the scienceCardiolpm combines deep learning with clinical expertise to redefine early detection, risk stratification, and personalized treatment pathways.
Seamlessly connected with leading medical device manufacturers and hospital networks.
Partnering with global healthcare leaders & academic medical centers
Our proprietary deep learning models detect over 95 distinct electrophysiological patterns covering 92% of common and rare arrhythmias, enabling early intervention and precision monitoring.
Explore the scienceWe are a health technology company focused on shifting cardiovascular care from reactive to proactive through ethically trained AI and real‑world data.
To eliminate preventable cardiac events globally by making AI‑driven cardiovascular insights accessible to every clinician and patient.
Class IIa Medical Device Software
Cardiolpm Core Platform certified under EU MDR and FDA breakthrough designation.
Cardiolpm Pulse is our cloud-native platform that helps cardiologists and primary care physicians triage critical cases, reduce reading time by 63%, and improve diagnostic confidence with AI‑powered insights.
Discover Pulse platformCardiolpm powers cardiovascular intelligence across industries
Accelerate drug development with AI‑derived ECG endpoints, digital biomarkers, and decentralized trial support.
Reduce readmissions, optimize telemetry monitoring, and scale expert cardiology capacity with AI co‑pilot tools.
Centralized cardiac safety monitoring, AI‑enhanced patient selection, and real‑time adverse event detection.
Sync your wearables, understand your heart trends, and share actionable reports with your specialist — all in one secure place.
Get the app →
Dr. Elena Mendez
Chief of Cardiology, Madrid Institute of Heart & Vascular Health
Our algorithms are trained on more than 12 million de‑identified ECGs spanning diverse geographies, ethnicities, and disease states — ensuring robust, equitable performance across populations.
Learn about our dataFor major arrhythmia detection in validation studies across 15 clinical sites.
Average reduction in ECG interpretation time for emergency departments.
Enterprise‑grade security with end‑to‑end encryption and audit trails.
Cardiolpm in the news and peer‑reviewed publications
Research highlight
Company milestone
Strategic partnership
Reach out to our team for demos, partnerships, or scientific collaboration
🏢 Cardiolpm HQ, 30 Madison Avenue, Suite 1400, New York, NY 10017, USA
📞 +1 (212) 555‑8930
📧 contact@cardiolpm.com
📧 support@cardiolpm.com
🕒 Mon-Fri: 8:00 AM – 8:00 PM EST
Dr. Sophia Laurent – CEO & Co‑founder
James O'Connor – Chief Technology Officer
Dr. Priya Kapoor – Chief Medical Officer
Cardiolpm is a privately held company backed by leading healthtech investors. For investor relations: ir@cardiolpm.com